BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38849235)

  • 21. Adjuvant radiotherapy for atypical meningiomas.
    Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
    J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy.
    Cain SA; Smoll NR; Van Heerden J; Tsui A; Drummond KJ
    J Clin Neurosci; 2015 Nov; 22(11):1742-8. PubMed ID: 26213286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
    Liu X; Shan B; Wang M; Xu J
    World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.
    Pessina F; Navarria P; Clerici E; Soffietti R; Nibali MC; Rudà R; Riva M; Scorsetti M; Bello L
    World Neurosurg; 2019 Mar; 123():e273-e279. PubMed ID: 30496926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).
    Weber DC; Ares C; Villa S; Peerdeman SM; Renard L; Baumert BG; Lucas A; Veninga T; Pica A; Jefferies S; Ricardi U; Miralbell R; Stelmes JJ; Liu Y; Collette L; Collette S
    Radiother Oncol; 2018 Aug; 128(2):260-265. PubMed ID: 29960684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractionated radiotherapy for surgically resected intracranial meningiomas: A multicentre retrospective cohort study.
    Wang JZ; Nassiri F; Landry AP; Patil V; Rebchuk A; Merali ZA; Gui C; Lee G; Rogers L; Sinha J; Patel Z; Zuccato JA; Voisin MR; Munoz D; Spears J; Cusimano MD; Das S; Makarenko S; Yip S; Gao A; Laperriere N; Tsang DS; Zadeh G
    Radiother Oncol; 2023 Nov; 188():109861. PubMed ID: 37619659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage Stereotactic Radiosurgery for Recurrent WHO Grade 2 and 3 Meningiomas: A Multicenter Study (STORM).
    Gallitto M; Sedor G; Lee A; Pasetsky J; Kinslow CJ; Santos GL; Obiri-Yeboah D; Kshettry VR; Helis CA; Chan MD; Beckham TH; McGovern SL; Matsui J; Palmer JD; Bell JB; Mellon EA; Lakomy D; Huang J; Boor I; Rusthoven CG; Sisti MB; Wang TJC
    Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38641234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post Surgical Management of WHO Grade II Meningiomas: Our Experience, the Role of Gamma Knife and a Literature Review.
    Migliorati K; Spatola G; Giudice L; de Graaf N; Bassetti C; Giorgi C; Fontanella M; Vivaldi O; Bignardi M; Franzin A
    Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36675987
    [No Abstract]   [Full Text] [Related]  

  • 29. Adjuvant radiotherapy and stereotactic radiosurgery in grade 3 meningiomas - a systematic review and meta-analysis.
    Bergner A; Maier AD; Mirian C; Mathiesen TI
    Neurosurg Rev; 2022 Aug; 45(4):2639-2658. PubMed ID: 35543810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
    Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
    Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
    Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
    Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
    Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
    J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.
    Park S; Cha YJ; Suh SH; Lee IJ; Lee KS; Hong CK; Kim JW
    J Cancer Res Clin Oncol; 2019 May; 145(5):1351-1360. PubMed ID: 30953136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection.
    Hardesty DA; Wolf AB; Brachman DG; McBride HL; Youssef E; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2013 Aug; 119(2):475-81. PubMed ID: 23394332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups.
    Chun SJ; Park SH; Park CK; Kim JW; Kim TM; Choi SH; Lee ST; Kim IH
    Radiother Oncol; 2018 Aug; 128(2):254-259. PubMed ID: 29937212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
    Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
    World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
    Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
    J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaplastic Meningioma: Clinical Characteristics, Prognostic Factors and Survival Outcome.
    Seo DO; Song SW; Kim YH; Hong CK; Kim JH
    Brain Tumor Res Treat; 2022 Oct; 10(4):244-254. PubMed ID: 36347639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
    Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
    Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.